Sector: Health Care

(Reuters) - A U.S. health advisory panel on Thursday issued a split vote on data for Pfizer Inc's drug to treat a rare neurodegenerative disease.

(Reuters) - Pfizer Inc said a U.S. health advisory panel voted against its drug to treat a rare neurodegenerative disease as the data did not show enough evidence of efficacy.

(Reuters) - Pfizer Inc said a U.S. health advisory panel voted against its drug to treat a rare neurodegenerative disease as the data did not show enough evidence of efficacy.

(Reuters) - U.S. generic drug maker Mylan Inc settled a patent infringement suit with Sunovion Pharmaceuticals Inc, a unit of Dainippon Sumitomo Pharma Co, related to the Japanese drugmaker's bronchitis medicine Brovana.

WASHINGTON (Reuters) - The U.S. Senate on Thursday showed near-unanimous support for a bill that helps fund the U.S. Food and Drug Administration, a regulatory powerhouse with sweeping influence over the foods Americans eat and the medicines they take.

Shares of some top pharmaceuticals companies were up at the close of trading:

Shares of some top medical devices companies were up at the close of trading:

Shares of some top managed care companies were up at the close of trading:

(Reuters) - Biopharmaceutical company Theravance Inc said it licensed its technology to manufacture antibiotic Vibativ to specialty medicines maker Hospira Inc.

NEW YORK (Reuters Health) - Doctors find a high number of malignant tumors when a state-wide skin cancer screening program is introduced, says a new study.

Onyx Pharmaceuticals Inc. shares rose Thursday after a Bernstein Research analyst started covering the stock with an "Outperform" rating, saying he thinks the company's blood cancer drug candidate will reach $1 billion in annual sales by 2016.

OAK BROOK, Ill., May 24 - McDonald's Corp investors soundly rejected a shareholder proposal that would have required the world's biggest fast-food chain to assess its impact on childhood obesity.

NEW YORK (Reuters Health) - Soy-rich diets have been linked to lower rates of heart disease, but a small study suggests that soy supplements may not do anything for older women's blood pressure.

A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:

Shares of some top pharmaceuticals companies are mixed at 1 p.m.: